Success Metrics

Clinical Success Rate
100.0%

Based on 10 completed trials

Completion Rate
100%(10/10)
Active Trials
1(8%)
Results Posted
30%(3 trials)

Phase Distribution

Ph not_applicable
11
85%
Ph phase_4
1
8%
Ph phase_2
1
8%

Phase Distribution

0

Early Stage

1

Mid Stage

1

Late Stage

Phase Distribution13 total trials
Phase 2Efficacy & side effects
1(7.7%)
Phase 4Post-market surveillance
1(7.7%)
N/ANon-phased studies
11(84.6%)

Highest Phase Reached

Phase 4

Trial Status & Enrollment

Completion Rate

90.9%

10 of 11 finished

Non-Completion Rate

9.1%

1 ended early

Currently Active

1

trials recruiting

Total Trials

13

all time

Status Distribution
Active(1)
Completed(10)
Terminated(1)
Other(1)

Detailed Status

Completed10
unknown1
Recruiting1
Withdrawn1

Development Timeline

Analytics

Development Status

Total Trials
13
Active
1
Success Rate
100.0%
Most Advanced
Phase 4

Trials by Phase

Phase 21 (7.7%)
Phase 41 (7.7%)
N/A11 (84.6%)

Trials by Status

unknown18%
completed1077%
recruiting18%
withdrawn18%

Recent Activity

Clinical Trials (13)

Drug Details

Intervention Type
BEHAVIORAL
Total Trials
13